ResMed Ready to Make Waves at 41st Annual J.P. Morgan Healthcare Conference

ResMed (NYSE: RMD, ASX: RMD) is pleased to announce that Mick Farrell, its chief executive officer, will take the stage at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023. Farrell will share his insights on the conference’s mainstage, beginning at 1:30 p.m. (Pacific Standard Time) at the Westin St. Francis in San Francisco, CA. Don’t miss out on this captivating opportunity to hear from one of the world’s leading innovators in healthcare technology.

The webcast replay of this audio-only event will be available shortly after its conclusion, so you can revisit the content for the next thirty days. Tune in and make sure you don’t miss out!

About ResMed

At ResMed (NYSE: RMD, ASX: RMD), we are revolutionizing the way we treat and keep people out of the hospital, enabling them to enjoy healthier, higher-quality lives. Our cutting-edge digital health technologies and cloud-connected medical devices are transforming care for people with sleep apnea, COPD, and other chronic diseases. Our expansive out-of-hospital software platforms help professionals and caregivers give their patients the best care possible in their preferred setting. By providing better care for patients, we are improving quality of life, reducing the burden of chronic disease, and lowering costs for consumers and healthcare systems all over the world.

Leave a Comment